Kane Biotech KNBIF Stock
Kane Biotech Price Chart
Kane Biotech KNBIF Financial and Trading Overview
| Kane Biotech stock price | 0.09 USD |
| Previous Close | 0.07 USD |
| Open | 0.07 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.07 - 0.07 USD |
| 52 Week Range | 0.06 - 0.11 USD |
| Volume | 10K USD |
| Avg. Volume | 5.72K USD |
| Market Cap | 9.38M USD |
| Beta (5Y Monthly) | 0.257816 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
KNBIF Valuation Measures
| Enterprise Value | 18.08M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.3718805 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 6.503 |
| Enterprise Value/EBITDA | -6.045 |
Trading Information
Kane Biotech Stock Price History
| Beta (5Y Monthly) | 0.257816 |
| 52-Week Change | -6.080% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.11 USD |
| 52 Week Low | 0.06 USD |
| 50-Day Moving Average | 0.08 USD |
| 200-Day Moving Average | 0.08 USD |
KNBIF Share Statistics
| Avg. Volume (3 month) | 5.72K USD |
| Avg. Daily Volume (10-Days) | 4.45K USD |
| Shares Outstanding | 124.85M |
| Float | 90.5M |
| Short Ratio | N/A |
| % Held by Insiders | 26.82% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -143.22% |
| Operating Margin (ttm) | -112.85% |
| Gross Margin | 56.63% |
| EBITDA Margin | -107.57% |
Management Effectiveness
| Return on Assets (ttm) | -35.19% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 2.78M USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | 19.80% |
| Gross Profit (ttm) | 1.41M USD |
| EBITDA | -2991190 USD |
| Net Income Avi to Common (ttm) | -3982403 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 990.08K USD |
| Total Cash Per Share (mrq) | 0.008 USD |
| Total Debt (mrq) | 7.94M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.389 |
| Book Value Per Share (mrq) | -0.062 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3178550 USD |
| Levered Free Cash Flow (ttm) | -3102984 USD |
Profile of Kane Biotech
| Country | United States |
| State | MB |
| City | Winnipeg |
| Address | 290-100 Innovation Drive |
| ZIP | R3T 6G2 |
| Phone | 204 453 1301 |
| Website | https://kanebiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; and animal and human wound care solutions under the DispersinB name. It also offers scalp care products under the DermaKB brand name; and wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, Aledex, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
Q&A For Kane Biotech Stock
What is a current KNBIF stock price?
Kane Biotech KNBIF stock price today per share is 0.09 USD.
How to purchase Kane Biotech stock?
You can buy KNBIF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kane Biotech?
The stock symbol or ticker of Kane Biotech is KNBIF.
Which industry does the Kane Biotech company belong to?
The Kane Biotech industry is Biotechnology.
How many shares does Kane Biotech have in circulation?
The max supply of Kane Biotech shares is 134.08M.
What is Kane Biotech Price to Earnings Ratio (PE Ratio)?
Kane Biotech PE Ratio is now.
What was Kane Biotech earnings per share over the trailing 12 months (TTM)?
Kane Biotech EPS is -0.02 USD over the trailing 12 months.
Which sector does the Kane Biotech company belong to?
The Kane Biotech sector is Healthcare.